Nicole Keith

Director/Board Member en SANA BIOTECHNOLOGY, INC. .

Health Technology

Perfil

Nicole Keith is currently working as an Investor Relations Contact at Juno Therapeutics, Inc. since 2015.
She is also currently working as an Investor Relations & Media professional at Sana Biotechnology, Inc. Additionally, Ms. Keith previously worked as the Head-Investor Relations at Onyx Pharmaceuticals, Inc. from 2012 to 2013.

Cargos activos de Nicole Keith

Empresas	Cargo	Inicio
JUNO THERAPEUTICS INC	Investor Relations Contact	01/07/2015
SANA BIOTECHNOLOGY, INC.	Director/Board Member	-

Todos los cargos activos de Nicole Keith

Antiguos cargos conocidos de Nicole Keith.

Empresas	Cargo	Fin
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Public Communications Contact	01/12/2013

Ver el detalle de la experiencia de Nicole Keith.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Nicole Keith.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
SANA BIOTECHNOLOGY, INC.	Health Technology

Empresas privadas	2
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Health Technology
Juno Therapeutics, Inc. Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA.	Health Technology